Mattila KE, Vainio P, Jaakkola PM. Prognostic factors for localized clear cell renal cell carcinoma and their application in adjuvant therapy. Cancers. 2022;14(1):239.
Article
CAS
Google Scholar
Hsieh JJ, Purdue MP, Signoretti S, Swanton C, Albiges L, Schmidinger M, et al. Renal cell carcinoma. Nat Rev Dis Primers. 2017;3:17009.
Article
Google Scholar
Boguslawska J, Kryst P, Poletajew S, Piekielko-Witkowska A. TGF-beta and microRNA interplay in genitourinary cancers. Cells. 2019;8(12):1619.
Article
CAS
Google Scholar
Peinado H, Zhang H, Matei IR, Costa-Silva B, Hoshino A, Rodrigues G, et al. Pre-metastatic niches: organ-specific homes for metastases. Nat Rev Cancer. 2017;17(5):302–17.
Article
CAS
Google Scholar
Reina-Campos M, Moscat J, Diaz-Meco M. Metabolism shapes the tumor microenvironment. Curr Opin Cell Biol. 2017;48:47–53.
Article
CAS
Google Scholar
de la Cruz-Lopez KG, Castro-Munoz LJ, Reyes-Hernandez DO, Garcia-Carranca A, Manzo-Merino J. Lactate in the regulation of tumor microenvironment and therapeutic approaches. Front Oncol. 2019;9:1143.
Article
Google Scholar
Pan T, Lin SC, Yu KJ, Yu G, Song JH, Lewis VO, et al. BIGH3 promotes osteolytic lesions in renal cell carcinoma bone metastasis by inhibiting osteoblast differentiation. Neoplasia. 2018;20(1):32–43.
Article
CAS
Google Scholar
Stehle F, Leisz S, Schulz K, Schwurack N, Weber N, Massa C, et al. VHL-dependent alterations in the secretome of renal cell carcinoma: association with immune cell response? Oncotarget. 2015;6(41):43420–37.
Article
Google Scholar
Boguslawska J, Piekielko-Witkowska A, Wojcicka A, Kedzierska H, Poplawski P, Nauman A. Regulatory feedback loop between T3 and microRNAs in renal cancer. Mol Cell Endocrinol. 2014;384(1–2):61–70.
Article
CAS
Google Scholar
Hanusek K, Rybicka B, Poplawski P, Adamiok-Ostrowska A, Gluchowska K, Piekielko-Witkowska A, et al. TGFbeta1 affects the renal cancer miRNome and regulates tumor cells proliferation. Int J Mol Med. 2022. https://doi.org/10.3892/ijmm.2022.5108.
Article
Google Scholar
Boguslawska J, Poplawski P, Alseekh S, Koblowska M, Iwanicka-Nowicka R, Rybicka B, et al. MicroRNA-mediated metabolic reprograming in renal cancer. Cancers. 2019;11(12):1825.
Article
CAS
Google Scholar
Pinski A, Betekhtin A, Skupien-Rabian B, Jankowska U, Jamet E, Hasterok R. Changes in the cell wall proteome of leaves in response to high temperature stress in Brachypodium distachyon. Int J Mol Sci. 2021;22(13):6750.
Article
CAS
Google Scholar
Poplawski P, Tohge T, Boguslawska J, Rybicka B, Tanski Z, Trevino V, et al. Integrated transcriptomic and metabolomic analysis shows that disturbances in metabolism of tumor cells contribute to poor survival of RCC patients. Biochim Biophys Acta Mol Basis Dis. 2017;1863(3):744–52.
Article
CAS
Google Scholar
Ge SX, Jung D, Yao R. ShinyGO: a graphical gene-set enrichment tool for animals and plants. Bioinformatics. 2020;36(8):2628–9.
Article
CAS
Google Scholar
Li T, Fu J, Zeng Z, Cohen D, Li J, Chen Q, et al. TIMER2.0 for analysis of tumor-infiltrating immune cells. Nucleic Acids Res. 2020;48(W1):W509–14.
Article
CAS
Google Scholar
Zhang Y, Chen F, Chandrashekar DS, Varambally S, Creighton CJ. Proteogenomic characterization of 2002 human cancers reveals pan-cancer molecular subtypes and associated pathways. Nat Commun. 2022;13(1):2669.
Article
CAS
Google Scholar
Chen F, Chandrashekar DS, Varambally S, Creighton CJ. Pan-cancer molecular subtypes revealed by mass-spectrometry-based proteomic characterization of more than 500 human cancers. Nat Commun. 2019;10(1):5679.
Article
CAS
Google Scholar
Chandrashekar DS, Karthikeyan SK, Korla PK, Patel H, Shovon AR, Athar M, et al. UALCAN: An update to the integrated cancer data analysis platform. Neoplasia. 2022;25:18–27.
Article
CAS
Google Scholar
Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Stat Soc: Ser B (Methodol). 1995;57(1):289–300.
Google Scholar
Gopal SK, Greening DW, Zhu HJ, Simpson RJ, Mathias RA. Transformed MDCK cells secrete elevated MMP1 that generates LAMA5 fragments promoting endothelial cell angiogenesis. Sci Rep. 2016;6:28321.
Article
CAS
Google Scholar
Mathias RA, Chen YS, Wang B, Ji H, Kapp EA, Moritz RL, et al. Extracellular remodelling during oncogenic Ras-induced epithelial-mesenchymal transition facilitates MDCK cell migration. J Proteome Res. 2010;9(2):1007–19.
Article
CAS
Google Scholar
Mathias RA, Wang B, Ji H, Kapp EA, Moritz RL, Zhu HJ, et al. Secretome-based proteomic profiling of Ras-transformed MDCK cells reveals extracellular modulators of epithelial-mesenchymal transition. J Proteome Res. 2009;8(6):2827–37.
Article
CAS
Google Scholar
Bundgaard L, Stensballe A, Elbaek KJ, Berg LC. Mass spectrometric analysis of the in vitro secretome from equine bone marrow-derived mesenchymal stromal cells to assess the effect of chondrogenic differentiation on response to interleukin-1beta treatment. Stem Cell Res Ther. 2020;11(1):187.
Article
CAS
Google Scholar
Ratushnyy A, Ezdakova M, Buravkova L. Secretome of senescent adipose-derived mesenchymal stem cells negatively regulates angiogenesis. Int J Mol Sci. 2020;21(5):1802.
Article
CAS
Google Scholar
Holmberg C, Ghesquiere B, Impens F, Gevaert K, Kumar JD, Cash N, et al. Mapping proteolytic processing in the secretome of gastric cancer-associated myofibroblasts reveals activation of MMP-1, MMP-2, and MMP-3. J Proteome Res. 2013;12(7):3413–22.
Article
CAS
Google Scholar
Robinson JL, Feizi A, Uhlen M, Nielsen J. A systematic investigation of the malignant functions and diagnostic potential of the cancer secretome. Cell Rep. 2019;26(10):2622-35 e5.
Article
CAS
Google Scholar
Miserey-Lenkei S, Bousquet H, Pylypenko O, Bardin S, Dimitrov A, Bressanelli G, et al. Coupling fission and exit of RAB6 vesicles at Golgi hotspots through kinesin-myosin interactions. Nat Commun. 2017;8(1):1254.
Article
Google Scholar
Greco MR, Bon E, Rubino R, Guerra L, Bernabe-Garcia M, Cannone S, et al. Phosphorylation of NHERF1 S279 and S301 differentially regulates breast cancer cell phenotype and metastatic organotropism. Biochim Biophys Acta Mol Basis Dis. 2019;1865(1):26–37.
Article
CAS
Google Scholar
Lamagna C, Hodivala-Dilke KM, Imhof BA, Aurrand-Lions M. Antibody against junctional adhesion molecule-C inhibits angiogenesis and tumor growth. Cancer Res. 2005;65(13):5703–10.
Article
CAS
Google Scholar
Kim C, Yang H, Fukushima Y, Saw PE, Lee J, Park JS, et al. Vascular RhoJ is an effective and selective target for tumor angiogenesis and vascular disruption. Cancer Cell. 2014;25(1):102–17.
Article
CAS
Google Scholar
Karagiannis GS, Schaeffer DF, Cho CK, Musrap N, Saraon P, Batruch I, et al. Collective migration of cancer-associated fibroblasts is enhanced by overexpression of tight junction-associated proteins claudin-11 and occludin. Mol Oncol. 2014;8(2):178–95.
Article
CAS
Google Scholar
Aoto K, Ito K, Aoki S. Complex formation between platelet-derived growth factor receptor beta and transforming growth factor beta receptor regulates the differentiation of mesenchymal stem cells into cancer-associated fibroblasts. Oncotarget. 2018;9(75):34090–102.
Article
Google Scholar
Fan J, Wang Y, Liu L, Zhang H, Zhang F, Shi L, et al. cTAGE5 deletion in pancreatic beta cells impairs proinsulin trafficking and insulin biogenesis in mice. J Cell Biol. 2017;216(12):4153–64.
Article
CAS
Google Scholar
Tanabe T, Maeda M, Saito K, Katada T. Dual function of cTAGE5 in collagen export from the endoplasmic reticulum. Mol Biol Cell. 2016;27(13):2008–13.
Article
Google Scholar
Wang Y, Liu L, Zhang H, Fan J, Zhang F, Yu M, et al. Mea6 controls VLDL transport through the coordinated regulation of COPII assembly. Cell Res. 2016;26(7):787–804.
Article
CAS
Google Scholar
Wilson DG, Phamluong K, Li L, Sun M, Cao TC, Liu PS, et al. Global defects in collagen secretion in a Mia3/TANGO1 knockout mouse. J Cell Biol. 2011;193(5):935–51.
Article
CAS
Google Scholar
Bombelli S, Torsello B, De Marco S, Lucarelli G, Cifola I, Grasselli C, et al. 36-kDa Annexin A3 isoform negatively modulates lipid storage in clear cell renal cell carcinoma cells. Am J Pathol. 2020;190(11):2317–26.
Article
CAS
Google Scholar
Yin J, Yan X, Yao X, Zhang Y, Shan Y, Mao N, et al. Secretion of annexin A3 from ovarian cancer cells and its association with platinum resistance in ovarian cancer patients. J Cell Mol Med. 2012;16(2):337–48.
Article
CAS
Google Scholar
Copello VA, Burnstein KL. The kinesin KIF20A promotes progression to castration-resistant prostate cancer through autocrine activation of the androgen receptor. Oncogene. 2022;41(20):2824–32.
Article
CAS
Google Scholar
Munoz I, Danelli L, Claver J, Goudin N, Kurowska M, Madera-Salcedo IK, et al. Kinesin-1 controls mast cell degranulation and anaphylaxis through PI3K-dependent recruitment to the granular Slp3/Rab27b complex. J Cell Biol. 2016;215(2):203–16.
Article
CAS
Google Scholar
Ursino GM, Fu Y, Cottle DL, Mukhamedova N, Jones LK, Low H, et al. ABCA12 regulates insulin secretion from beta-cells. EMBO Rep. 2020;21(3): e48692.
Article
CAS
Google Scholar
Lane TF, Iruela-Arispe ML, Johnson RS, Sage EH. SPARC is a source of copper-binding peptides that stimulate angiogenesis. J Cell Biol. 1994;125(4):929–43.
Article
CAS
Google Scholar
Bellenghi M, Talarico G, Botti L, Puglisi R, Tabolacci C, Portararo P, et al. SCD5-dependent inhibition of SPARC secretion hampers metastatic spreading and favors host immunity in a TNBC murine model. Oncogene. 2022;41(34):4055–65.
Article
CAS
Google Scholar
Bao JM, Dang Q, Lin CJ, Lo UG, Feldkoren B, Dang A, et al. SPARC is a key mediator of TGF-beta-induced renal cancer metastasis. J Cell Physiol. 2021;236(3):1926–38.
Article
CAS
Google Scholar
Rivera LB, Brekken RA. SPARC promotes pericyte recruitment via inhibition of endoglin-dependent TGF-beta1 activity. J Cell Biol. 2011;193(7):1305–19.
Article
CAS
Google Scholar
Tichet M, Prod’Homme V, Fenouille N, Ambrosetti D, Mallavialle A, Cerezo M, et al. Tumour-derived SPARC drives vascular permeability and extravasation through endothelial VCAM1 signalling to promote metastasis. Nat Commun. 2015;6:6993.
Article
CAS
Google Scholar
Tumbarello DA, Andrews MR, Brenton JD. SPARC regulates transforming growth factor beta induced (TGFBI) extracellular matrix deposition and paclitaxel response in ovarian cancer cells. PLoS ONE. 2016;11(9): e0162698.
Article
Google Scholar
Zhang Y, Udayakumar D, Cai L, Hu Z, Kapur P, Kho EY, et al. Addressing metabolic heterogeneity in clear cell renal cell carcinoma with quantitative Dixon MRI. JCI Insight. 2017;2(15): e94278.
Article
Google Scholar
Tseng C, Kolonin MG. Proteolytic isoforms of SPARC induce adipose stromal cell mobilization in obesity. Stem Cells. 2016;34(1):174–90.
Article
CAS
Google Scholar
Mhaidly R, Mechta-Grigoriou F. Role of cancer-associated fibroblast subpopulations in immune infiltration, as a new means of treatment in cancer. Immunol Rev. 2021;302(1):259–72.
Article
CAS
Google Scholar
Khan SS, Shah SJ, Klyachko E, Baldridge AS, Eren M, Place AT, et al. A null mutation in SERPINE1 protects against biological aging in humans. Sci Adv. 2017;3(11):eaao1617.
Article
Google Scholar
Chen CY, Chi LM, Chi HC, Tsai MM, Tsai CY, Tseng YH, et al. Stable isotope labeling with amino acids in cell culture (SILAC)-based quantitative proteomics study of a thyroid hormone-regulated secretome in human hepatoma cells. Mol Cell Proteomics. 2012;11(4):M111 011270.
Article
Google Scholar
Ghosh AK, Vaughan DE. PAI-1 in tissue fibrosis. J Cell Physiol. 2012;227(2):493–507.
Article
CAS
Google Scholar
Ramdas P, Radhakrishnan AK, Abdu Sani AA, Abdul-Rahman PS. Tocotrienols modulate breast cancer secretomes and affect cancer-signaling pathways in MDA-MB-231 cells: a label-free quantitative proteomic analysis. Nutr Cancer. 2019;71(8):1263–71.
Article
CAS
Google Scholar
Kang J, Kim W, Kwon T, Youn H, Kim JS, Youn B. Plasminogen activator inhibitor-1 enhances radioresistance and aggressiveness of non-small cell lung cancer cells. Oncotarget. 2016;7(17):23961–74.
Article
Google Scholar
Tarassishin L, Lim J, Weatherly DB, Angeletti RH, Lee SC. Interleukin-1-induced changes in the glioblastoma secretome suggest its role in tumor progression. J Proteomics. 2014;99:152–68.
Article
CAS
Google Scholar
Almeida J, Costa J, Coelho P, Cea V, Galesio M, Noronha JP, et al. Adipocyte proteome and secretome influence inflammatory and hormone pathways in glioma. Metab Brain Dis. 2019;34(1):141–52.
Article
CAS
Google Scholar
Sanchez C, Mazzucchelli G, Lambert C, Comblain F, DePauw E, Henrotin Y. Comparison of secretome from osteoblasts derived from sclerotic versus non-sclerotic subchondral bone in OA: a pilot study. PLoS ONE. 2018;13(3): e0194591.
Article
Google Scholar
Bagordakis E, Sawazaki-Calone I, Macedo CC, Carnielli CM, de Oliveira CE, Rodrigues PC, et al. Secretome profiling of oral squamous cell carcinoma-associated fibroblasts reveals organization and disassembly of extracellular matrix and collagen metabolic process signatures. Tumour Biol. 2016;37(7):9045–57.
Article
CAS
Google Scholar
Bakopoulou A, Kritis A, Andreadis D, Papachristou E, Leyhausen G, Koidis P, et al. Angiogenic potential and secretome of human apical papilla mesenchymal stem cells in various stress microenvironments. Stem Cells Dev. 2015;24(21):2496–512.
Article
CAS
Google Scholar
Needham EJ, Humphrey SJ, Cooke KC, Fazakerley DJ, Duan X, Parker BL, et al. Phosphoproteomics of acute cell stressors targeting exercise signaling networks reveal drug interactions regulating protein secretion. Cell Rep. 2019;29(6):1524-38 e6.
Article
CAS
Google Scholar
Liu RJ, Xu ZP, Li SY, Yu JJ, Feng NH, Xu B, et al. BAP1-related ceRNA (NEAT1/miR-10a-5p/SERPINE1) promotes proliferation and migration of kidney cancer cells. Front Oncol. 2022;12: 852515.
Article
Google Scholar
Sui Y, Lu K, Fu L. Prediction and analysis of novel key genes ITGAX, LAPTM5, SERPINE1 in clear cell renal cell carcinoma through bioinformatics analysis. PeerJ. 2021;9: e11272.
Article
Google Scholar
Liu W, Chen H, Wong N, Haynes W, Baker CM, Wang X. Pseudohypoxia induced by miR-126 deactivation promotes migration and therapeutic resistance in renal cell carcinoma. Cancer Lett. 2017;394:65–75.
Article
CAS
Google Scholar
Steitz AM, Steffes A, Finkernagel F, Unger A, Sommerfeld L, Jansen JM, et al. Tumor-associated macrophages promote ovarian cancer cell migration by secreting transforming growth factor beta induced (TGFBI) and tenascin C. Cell Death Dis. 2020;11(4):249.
Article
CAS
Google Scholar
Liu M, Iosef C, Rao S, Domingo-Gonzalez R, Fu S, Snider P, et al. Transforming growth factor-induced protein promotes NF-kappaB-mediated angiogenesis during postnatal lung development. Am J Respir Cell Mol Biol. 2021;64(3):318–30.
Article
CAS
Google Scholar
Caccia D, Zanetti Domingues L, Micciche F, De Bortoli M, Carniti C, Mondellini P, et al. Secretome compartment is a valuable source of biomarkers for cancer-relevant pathways. J Proteome Res. 2011;10(9):4196–207.
Article
CAS
Google Scholar
Lecker LSM, Berlato C, Maniati E, Delaine-Smith R, Pearce OMT, Heath O, et al. TGFBI production by macrophages contributes to an immunosuppressive microenvironment in ovarian cancer. Cancer Res. 2021;81(22):5706–19.
Article
CAS
Google Scholar
Nummela P, Lammi J, Soikkeli J, Saksela O, Laakkonen P, Holtta E. Transforming growth factor beta-induced (TGFBI) is an anti-adhesive protein regulating the invasive growth of melanoma cells. Am J Pathol. 2012;180(4):1663–74.
Article
CAS
Google Scholar
Ma C, Rong Y, Radiloff DR, Datto MB, Centeno B, Bao S, et al. Extracellular matrix protein betaig-h3/TGFBI promotes metastasis of colon cancer by enhancing cell extravasation. Genes Dev. 2008;22(3):308–21.
Article
Google Scholar
Sadvakassova G, Tiedemann K, Steer KJD, Mikolajewicz N, Stavnichuk M, In-Kyung Lee I, et al. Active hematopoiesis triggers exosomal release of PRDX2 that promotes osteoclast formation. Physiol Rep. 2021;9(3): e14745.
Article
CAS
Google Scholar
Kontostathi G, Zoidakis J, Makridakis M, Lygirou V, Mermelekas G, Papadopoulos T, et al. Cervical cancer cell line secretome highlights the roles of transforming growth factor-beta-induced protein ig-h3, peroxiredoxin-2, and NRF2 on cervical carcinogenesis. Biomed Res Int. 2017;2017:4180703.
Article
Google Scholar
Checconi P, Salzano S, Bowler L, Mullen L, Mengozzi M, Hanschmann EM, et al. Redox proteomics of the inflammatory secretome identifies a common set of redoxins and other glutathionylated proteins released in inflammation, influenza virus infection and oxidative stress. PLoS ONE. 2015;10(5): e0127086.
Article
Google Scholar
Salzano S, Checconi P, Hanschmann EM, Lillig CH, Bowler LD, Chan P, et al. Linkage of inflammation and oxidative stress via release of glutathionylated peroxiredoxin-2, which acts as a danger signal. Proc Natl Acad Sci USA. 2014;111(33):12157–62.
Article
CAS
Google Scholar
Nicolussi A, D’Inzeo S, Capalbo C, Giannini G, Coppa A. The role of peroxiredoxins in cancer. Mol Clin Oncol. 2017;6(2):139–53.
Article
CAS
Google Scholar
Senbabaoglu Y, Gejman RS, Winer AG, Liu M, Van Allen EM, de Velasco G, et al. Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures. Genome Biol. 2016;17(1):231.
Article
Google Scholar
Lichtenfels R, Mougiakakos D, Johansson CC, Dressler SP, Recktenwald CV, Kiessling R, et al. Comparative expression profiling of distinct T cell subsets undergoing oxidative stress. PLoS ONE. 2012;7(7): e41345.
Article
CAS
Google Scholar
Mayle KM, Le AM, Kamei DT. The intracellular trafficking pathway of transferrin. Biochim Biophys Acta. 2012;1820(3):264–81.
Article
CAS
Google Scholar
Schnetz M, Meier JK, Rehwald C, Mertens C, Urbschat A, Tomat E, et al. The disturbed iron phenotype of tumor cells and macrophages in renal cell carcinoma influences tumor growth. Cancers. 2020;12(3):530.
Article
CAS
Google Scholar
Greene CJ, Attwood K, Sharma NJ, Gross KW, Smith GJ, Xu B, et al. Transferrin receptor 1 upregulation in primary tumor and downregulation in benign kidney is associated with progression and mortality in renal cell carcinoma patients. Oncotarget. 2017;8(63):107052–75.
Article
Google Scholar
Wagner L, Klemann C, Stephan M, von Horsten S. Unravelling the immunological roles of dipeptidyl peptidase 4 (DPP4) activity and/or structure homologue (DASH) proteins. Clin Exp Immunol. 2016;184(3):265–83.
Article
CAS
Google Scholar
Maes MB, Scharpe S, De Meester I. Dipeptidyl peptidase II (DPPII), a review. Clin Chim Acta. 2007;380(1–2):31–49.
Article
CAS
Google Scholar
Fu Q, Xu L, Wang Y, Jiang Q, Liu Z, Zhang J, et al. Tumor-associated macrophage-derived interleukin-23 interlinks kidney cancer glutamine addiction with immune evasion. Eur Urol. 2019;75(5):752–63.
Article
CAS
Google Scholar
Keshari KR, Sriram R, Koelsch BL, Van Criekinge M, Wilson DM, Kurhanewicz J, et al. Hyperpolarized 13C-pyruvate magnetic resonance reveals rapid lactate export in metastatic renal cell carcinomas. Cancer Res. 2013;73(2):529–38.
Article
CAS
Google Scholar
Fisel P, Kruck S, Winter S, Bedke J, Hennenlotter J, Nies AT, et al. DNA methylation of the SLC16A3 promoter regulates expression of the human lactate transporter MCT4 in renal cancer with consequences for clinical outcome. Clin Cancer Res. 2013;19(18):5170–81.
Article
CAS
Google Scholar
Wu JY, Huang TW, Hsieh YT, Wang YF, Yen CC, Lee GL, et al. Cancer-derived succinate promotes macrophage polarization and cancer metastasis via succinate receptor. Mol Cell. 2020;77(2):213-27 E5.
Article
CAS
Google Scholar
Fourriere L, Jimenez AJ, Perez F, Boncompain G. The role of microtubules in secretory protein transport. J Cell Sci. 2020;133(2): jcs237016.
Article
CAS
Google Scholar
Ketchem CJ, Khundmiri SJ, Gaweda AE, Murray R, Clark BJ, Weinman EJ, et al. Role of Na+/H+ exchanger regulatory factor 1 in forward trafficking of the type IIa Na+-Pi cotransporter. Am J Physiol Renal Physiol. 2015;309(2):F109–19.
Article
CAS
Google Scholar
Hoque MT, Conseil G, Cole SP. Involvement of NHERF1 in apical membrane localization of MRP4 in polarized kidney cells. Biochem Biophys Res Commun. 2009;379(1):60–4.
Article
CAS
Google Scholar
Zhu Q, Pan QZ, Zhong AL, Hu H, Zhao JJ, Tang Y, et al. Annexin A3 upregulates the infiltrated neutrophil-lymphocyte ratio to remodel the immune microenvironment in hepatocellular carcinoma. Int Immunopharmacol. 2020;89(Pt A): 107139.
Article
CAS
Google Scholar
Selli C, Cozzolino F, Carini M, Lenzi R, Vercelli D. Serum beta 2 microglobulin levels in patients with renal cell carcinoma. Urol Res. 1984;12(5):261–3.
Article
CAS
Google Scholar
Senturk A, Sahin AT, Armutlu A, Kiremit MC, Acar O, Erdem S, et al. Quantitative proteomics identifies secreted diagnostic biomarkers as well as tumor-dependent prognostic targets for clear cell renal cell carcinoma. Mol Cancer Res. 2021;19(8):1322–37.
Article
CAS
Google Scholar
Vizcaino JA, Deutsch EW, Wang R, Csordas A, Reisinger F, Rios D, et al. ProteomeXchange provides globally coordinated proteomics data submission and dissemination. Nat Biotechnol. 2014;32(3):223–6.
Article
CAS
Google Scholar